{"resolution": {"@star-print": "no-star-print", "@resolution-stage": "Introduced-in-Senate", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "@display": "yes", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "S. RES. 393"}, "official-title": {"#tail": "\n\t", "@display": "yes", "#text": "Supporting the goals of World Tuberculosis Day to raise awareness about tuberculosis."}, "session": {"#tail": "\n\t\t", "@display": "yes", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "III"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140324", "#text": "March 24, 2014"}, "#tail": "\n\t\t", "@display": "yes", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "SSFR00", "#text": "Committee on Foreign Relations"}, "sponsor": {"#tail": " (for himself and ", "#text": "Mr. Brown", "@name-id": "S307"}, "cosponsor": {"#tail": ") submitted the following resolution; which was referred to the ", "#text": "Mr. Isakson", "@name-id": "S305"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "RESOLUTION"}}, "@resolution-type": "senate-resolution", "resolution-body": {"#tail": "\n", "section": {"@section-type": "undesignated-section", "#tail": "\n  ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "federal-body", "#text": "Senate", "@entity-id": "0010"}, "#text": "That the "}, "enum": {"#tail": "\n      "}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "supports the goals of World Tuberculosis Day to raise awareness about tuberculosis;"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "id8cb3ae1f24aa49ad8439bd3f45974390", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "federal-body", "#text": "United States\n\t\t\t Agency for International Development", "@entity-id": "7200"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Centers for Disease Control and\n\t\t\t Prevention", "@entity-id": "7523"}, {"#tail": ", and the Global Fund to\n\t\t\t Fight AIDS, Tuberculosis, and Malaria; and", "@entity-type": "federal-body", "#text": "National Institutes of Health", "@entity-id": "7529"}], "#text": "commends the progress of anti-tuberculosis efforts by entities that include the "}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "id723e0ab8e9454cff9282e2f7ca8054d6", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "reaffirms the commitment to global tuberculosis control set forth in ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 4 of the United States\n\t\t\t Leadership\n\t\t\t Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003", "@value": "United States Leadership Against HIV-AIDS, Tuberculosis, and Malaria Act of 2003/s:4"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "22 U.S.C. 7603", "@value": "usc/22/7603"}, "@parsable-cite": "usc/22/7603", "#text": "\n            ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "id18606114f6e94e0aa41cd84664bf508f", "#text": "\n        "}], "@display-inline": "yes-display-inline", "#text": "\n      ", "@id": "S1"}, "#text": "\n\t\t"}, "@public-private": "public", "#text": "\n\t", "preamble": {"#tail": "\n\t", "whereas": [{"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas ", "fraction": {"#tail": "  of the population of the world is infected with the tuberculosis bacterium;", "#text": "1/3"}}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas more than 9,500 tuberculosis  cases were reported in the United States in 2013;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas more than 1,300,000 individuals die from tuberculosis each year;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas over 95 percent of tuberculosis deaths occur in low- and middle-income developing\n\t\t\t countries;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas tuberculosis is the second leading global infectious disease killer, behind HIV/AIDS, and\n\t\t\t claims 1,800,000 lives each year;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas tuberculosis is a leading killer of people living with HIV/AIDS, causing ", "fraction": {"#tail": " of all deaths\n\t\t\t among people with HIV/AIDS;", "#text": "1/5"}}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas tuberculosis is the third leading killer of adult women, and the stigma associated with\n\t\t\t tuberculosis disproportionately affects women, causing women to delay\n\t\t\t seeking care and interfering with treatment adherence;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas the global tuberculosis pandemic and the spread of drug-resistant tuberculosis present a\n\t\t\t persistent public health threat to the United States;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", 3.6 percent of all new\n\t\t\t tuberculosis cases are drug resistant;", "@entity-type": "federal-body", "#text": "World Health Organization", "@entity-id": "19UH"}, "#text": "Whereas according to 2009 data from the "}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "quote": {"#tail": ") is present in virtually all countries surveyed;", "#text": "MDR-TB"}, "#text": "Whereas multi-drug resistant tuberculosis (referred to in this preamble as "}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas approximately 450,000 people around the world developed MDR-TB in 2012;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "quote": {"#tail": ") is a strain of tuberculosis that is very difficult and expensive to treat and has high and rapid\n\t\t\t fatality rates, especially among HIV/AIDS patients;", "#text": "XDR-TB"}, "#text": "Whereas extensively drug-resistant tuberculosis (referred to in this preamble as "}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas there have been more than 63 cases of XDR-TB in the United States between 2004 and 2014;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas as of September 2013, 92 countries have reported at least 1 case of XDR-TB;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " estimated, in 2009, that the cost of\n\t\t\t hospitalizing a single patient with XDR-TB is $483,000;", "@entity-type": "federal-body", "#text": "Centers for Disease Control and Prevention", "@entity-id": "7523"}, "#text": "Whereas the "}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas, between 2005 and 2007, the 373 XDR-TB cases in the United States collectively cost the\n\t\t\t health care system an estimated $53,000,000;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas the death rate of tuberculosis dropped 45 percent between 1990 and 2012;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas the Institute of Medicine found that a decrease in tuberculosis  control funding and the\n\t\t\t spread of HIV/AIDS caused the resurgence of tuberculosis between 1980 and\n\t\t\t 1992;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas although the number of tuberculosis cases in the United States continues to decline,\n\t\t\t progress towards eliminating tuberculosis has slowed and the disease does\n\t\t\t not recognize borders;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas African Americans are 8 times more likely to have tuberculosis than Caucasians, and\n\t\t\t significant disparities exist among other minorities in the United States,\n\t\t\t including Native Americans, Asian Americans, and Hispanic Americans;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas over 530,000 children became infected with tuberculosis in 2012;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas tobacco use greatly increases the risk of tuberculosis and death, and more than 20 percent\n\t\t\t of tuberculosis cases worldwide are attributed to smoking;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas diabetes is a major risk factor for tuberculosis, and people with diabetes are more likely\n\t\t\t to develop\n\t\t\t the disease and have a higher risk of death due to the disease;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas a new technology, known as Xpert,  developed in the United States, is able to diagnose\n\t\t\t cases of tuberculosis within 2 hours, and such technology can even\n\t\t\t diagnose cases that are difficult to detect, such as cases involving\n\t\t\t individuals living with HIV;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas although drugs, diagnostics, and vaccines for tuberculosis exist, these technologies are\n\t\t\t antiquated and increasingly inadequate for controlling the global\n\t\t\t epidemic;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas Xpert can quickly detect resistance to 1 of the primary tuberculosis drugs, but other tests\n\t\t\t to detect drug resistance take at least 1 month to complete and the\n\t\t\t medical community must develop even faster drug susceptibility tests to\n\t\t\t stop the spread of drug-resistant tuberculosis;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "quote": {"#tail": ", provides some protection to children but has little or no efficacy in preventing pulmonary\n\t\t\t tuberculosis in adults;", "#text": "BCG"}, "#text": "Whereas Bacillus Calmette-Gu\u00e9rin,  a tuberculosis vaccine that is known as "}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas there is a critical need for the development of tuberculosis drugs that individuals  can\n\t\t\t safely take concurrently with antiretroviral therapy for HIV;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " is to reverse the spread\n\t\t\t of tuberculosis by 2015;", "@entity-type": "federal-body", "#text": "World Health Organization", "@entity-id": "19UH"}, "#text": "Whereas the Millennium Development Goal of the "}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas the enactment of the ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": " and the ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Tom Lantos and Henry J. Hyde United States Global Leadership Against\n\t\t\t HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008", "@value": "Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV-AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008"}, {"#tail": "; ", "@entity-type": "public-law", "#text": "Public\n\t\t\t Law 110\u2013293", "@value": "public-law/110/293"}, {"#tail": ")", "@entity-type": "statute-at-large", "#text": "122 Stat. 2918", "@value": "statute-at-large/122/2918"}], "@entity-type": "law-citation", "#text": "\n          "}, {"#tail": " provides a\n\t\t\t historic United States commitment to the global eradication of\n\t\t\t tuberculosis, including  a commitment to successfully treating 4,500,000\n\t\t\t tuberculosis patients and 90,000 MDR-TB patients between 2008 and 2013 and\n\t\t\t to providing additional treatment through coordinated multilateral\n\t\t\t efforts;", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Comprehensive Tuberculosis\n\t\t\t Elimination Act of 2008", "@value": "Comprehensive Tuberculosis Elimination Act of 2008"}, {"#tail": ")", "@entity-type": "statute-at-large", "#text": "122 Stat. 4195", "@value": "statute-at-large/122/4195"}], "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": "; ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "public-law", "#text": "Public Law 110\u2013392", "@value": "public-law/110/392"}, "@parsable-cite": "pl/110/392", "#text": "\n          ", "@legal-doc": "public-law"}}]}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " provides financial and technical\n\t\t\t assistance to nearly 40 highly burdened tuberculosis countries, supports\n\t\t\t the development of new diagnostic and treatment tools, and is authorized\n\t\t\t to support research to develop new vaccines to combat tuberculosis;", "@entity-type": "federal-body", "#text": "United States Agency for International Development", "@entity-id": "7200"}, "#text": "Whereas the "}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", partnering with the other entities of the\n\t\t\t United States and individual States and territories, directs the national\n\t\t\t tuberculosis elimination program, directs essential national tuberculosis\n\t\t\t surveillance, technical assistance, and prevention activities, and\n\t\t\t supports the development of new diagnostic, treatment, and prevention\n\t\t\t tools to combat tuberculosis;", "@entity-type": "federal-body", "#text": "Centers for Disease Control and Prevention", "@entity-id": "7523"}, "#text": "Whereas the "}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", through its many institutes and centers, plays the\n\t\t\t leading role in basic and clinical research on the identification,\n\t\t\t treatment, and prevention of tuberculosis;", "@entity-type": "federal-body", "#text": "National Institutes of Health", "@entity-id": "7529"}, "#text": "Whereas the "}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas the Global Fund to Fight AIDS, Tuberculosis, and Malaria provides 63 percent of all\n\t\t\t international financing for tuberculosis programs;"}, "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "Whereas the Global Fund to Fight AIDS, Tuberculosis, and Malaria finances\u2014"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "proposals worth $3,200,000,000 in 112 countries;"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "id50B3786319374D358AEA534AA9E1E868", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "tuberculosis treatment for 6,000,000 people; and"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "idA3AB3BAA327043BBAA5282B74A634094", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "1,800,000 HIV/AIDS and tuberculosis services;"}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "idF86B93B4E4164E6F9DBD87E402953903", "#text": "\n        "}], "#text": "\n      "}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "Whereas the prevalence and mortality rates of tuberculosis are declining in many countries with\n\t\t\t programs supported by the Global Fund to Fight AIDS, Tuberculosis, and\n\t\t\t Malaria; and"}, "#text": "\n      "}, {"#tail": "\n  ", "text": {"#tail": "\n\t\t", "#text": "Whereas March 24, 2014, is World Tuberculosis Day, a day that commemorates the date in 1882 on\n\t\t\t which Dr. Robert Koch announced his discovery of Mycobacterium\n\t\t\t tuberculosis, the bacteria that causes tuberculosis: Now, therefore, be it"}, "#text": "\n      "}], "#text": "\n\t\t"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-03-24"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 SRES 393 IS: Supporting the goals of World Tuberculosis Day to raise awareness about tuberculosis."}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}